Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

188.09
+0.94000.50%
Post-market: 184.49-3.6000-1.91%19:59 EDT
Volume:5.77M
Turnover:1.09B
Market Cap:332.73B
PE:80.38
High:190.18
Open:188.17
Low:186.75
Close:187.15
Loading ...

AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?

Zacks
·
02 Apr

High Growth Tech Stocks To Watch In The US April 2025

Simply Wall St.
·
01 Apr

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Apr

AbbVie to Host First-Quarter 2025 Earnings Conference Call

PR Newswire
·
31 Mar

These 15 stocks are the most profitable companies in the S&P 500

Dow Jones
·
31 Mar

AbbVie Inc. (ABBV): Among the Best Dividend Aristocrat Stocks with Over 3% Yield

Insider Monkey
·
31 Mar

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
29 Mar

Exclusive-Drugmakers Sending More Medicines by Air to U.S. Ahead of Potential Tariffs -Execs, Logistics Firms

THOMSON REUTERS
·
27 Mar

From Rookie Mistakes To $10K/Year In Dividends – Military Veteran Who 'Made A Few Great Plays' Shares His 10 Biggest Bets

Benzinga
·
27 Mar

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

Zacks
·
27 Mar

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Zacks
·
27 Mar

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...

GuruFocus.com
·
27 Mar

AbbVie (NYSE:ABBV) Showcases Oncology Innovations Amidst 6% Share Price Dip

Simply Wall St.
·
27 Mar

AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025

PR Newswire
·
26 Mar

These Dividend Aristocrats' Stocks Can Protect You From the Market Selloff -- Barrons.com

Dow Jones
·
26 Mar

AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why

Zacks
·
25 Mar

BRIEF-Abbvie CEO Robert A. Michael's 2024 Total Compensation Was $18.5 Million - Filing

Reuters
·
25 Mar

Abbvie: Executive Chairman Richard a. Gonzalez's 2024 Total Compensation Was $28.5 Mln - Filing

THOMSON REUTERS
·
25 Mar

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires Live
·
24 Mar

Genmab Denies Trade Secret Misappropriation Claims by AbbVie

MT Newswires Live
·
24 Mar